SCHEMBL6904702

SCHEMBL6904702

Cc1cc(=O)oc2cc(O)cc(N)c12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.70
HSD17B10 Q99714 6/20 0.70
HPGD P15428 5/20 0.70
CASP1 P29466 4/20 0.70
CASP7 P55210 4/20 0.70
CA9 Q16790 3/20 0.70
CYP3A4 P08684 3/20 0.70
TSHR P16473 3/20 0.70
KDM4E B2RXH2 7/20 0.51
GAA P10253 7/20 0.51
GLA P06280 4/20 0.51
MCL1 Q07820 3/20 0.51
KDR P35968 2/20 0.51
AKR1B1 P15121 2/20 0.51
LMNA P02545 2/20 0.51
CA12 O43570 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
UGT1A1 P22309 1/20 0.51
MAOB P27338 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11215292 0.85 ALDH1A1 (0.79) ALDH1A1HSD17B10HPGDCASP1CASP7
Formaldehyde SCHEMBL27728506 0.82 ALDH1A1 (0.74) ALDH1A1HSD17B10HPGDCASP1CASP7
5,7-Dihydroxy-4-Methylcoumarin SCHEMBL403833 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10HPGDCASP1CASP7
5,7-Dihydroxy-4-Methylcoumarin SCHEMBL29431030 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10HPGDCASP1CASP7
5,7-Dihydroxy-4-Methylcoumarin SCHEMBL4395631 0.81 ALDH1A1 (0.96) ALDH1A1HSD17B10HPGDCASP1CASP7
SCHEMBL22031602 0.79 ALDH1A1 (0.70) ALDH1A1HSD17B10HPGDCASP1CASP7
SCHEMBL5118377 0.79 ALDH1A1 (0.86) ALDH1A1HSD17B10HPGDCASP1CASP7
SCHEMBL22752752 0.77 ALDH1A1 (0.66) ALDH1A1HSD17B10HPGDCASP1CASP7
SCHEMBL12459174 0.77 ALDH1A1 (0.66) ALDH1A1HSD17B10HPGDCASP1CASP7
SCHEMBL11095245 0.77 ALDH1A1 (0.69) ALDH1A1HSD17B10HPGDCASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040053893-A1 Method of assaying iysophospholipase d activity AZWELL INC. (JP) 2004-03-18 US disclosed
EP-1357126-A1 METHOD OF ASSAYING LYSOPHOSPHOLIPASE D ACTIVITY Azwell Inc. (JP) 2003-10-29 EP disclosed
US-5011964-A Phospholipase cleavage of water-insoluble ester yields chromogen for colorimetric analysis CORNELL RESEARCH FOUNDATION, INC. (US) 1991-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053893-A1 Method of assaying iysophospholipase d activity LYPLA1, LPL, LYPLA2 ALDH1A1 717/4885HSD17B10 242/4885HPGD 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.